Cargando…

Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021

Detalles Bibliográficos
Autores principales: Bajema, Kristina L., Dahl, Rebecca M., Evener, Steve L., Prill, Mila M., Rodriguez-Barradas, Maria C., Marconi, Vincent C., Beenhouwer, David O., Holodniy, Mark, Lucero-Obusan, Cynthia, Brown, Sheldon T., Tremarelli, Maraia, Epperson, Monica, Mills, Lisa, Park, So Hee, Rivera-Dominguez, Gilberto, Morones, Rosalba Gomez, Ahmadi-Izadi, Ghazal, Deovic, Rijalda, Mendoza, Chad, Jeong, Chan, Schrag, Stephanie J., Meites, Elissa, Hall, Aron J., Kobayashi, Miwako, McMorrow, Meredith, Verani, Jennifer R., Thornburg, Natalie J., Surie, Diya, Burnette, Joy, Capo, Gustavo, Epstein, Lauren, Gallini, Julia, Harrison, Telisha, Hartley, Amy, Hernandez, Liliana, Morales, Elena, Patel, Nina, Rooney, Kim, Tanner, Tehquin, Tate, Ernest, Tunson, Ashley, Whitmire, Alexis, Winston, Juton, Elliot, Katherine, Graham, Ilda, Lama, Diki, Pena, Ismael, Perea, Adrienne, Perez, Guerry Anabelle, Simelane, Johane, Smith, Sarah, Tallin, Gabriela, Tisi, Amelia, Lopez, Alonso Arellano, Gonzalez, Miguel Covarrubias, Lengi, Bashir, Tamez, Mariana Vanoye, Aryanfar, Babak, Lee-Chang, Ian, Matolek, Anthony, Poteshkina, Aleksandra, Naeem, Saadia, Goldin, Evan, Agrawal, Madhuri, Lopez, Jessica, Peters, Theresa, Kudryavtseva, Geliya, Cates, Jordan, Kambhampati, Anita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659185/
https://www.ncbi.nlm.nih.gov/pubmed/34882654
http://dx.doi.org/10.15585/mmwr.mm7049a2
_version_ 1784612904820015104
author Bajema, Kristina L.
Dahl, Rebecca M.
Evener, Steve L.
Prill, Mila M.
Rodriguez-Barradas, Maria C.
Marconi, Vincent C.
Beenhouwer, David O.
Holodniy, Mark
Lucero-Obusan, Cynthia
Brown, Sheldon T.
Tremarelli, Maraia
Epperson, Monica
Mills, Lisa
Park, So Hee
Rivera-Dominguez, Gilberto
Morones, Rosalba Gomez
Ahmadi-Izadi, Ghazal
Deovic, Rijalda
Mendoza, Chad
Jeong, Chan
Schrag, Stephanie J.
Meites, Elissa
Hall, Aron J.
Kobayashi, Miwako
McMorrow, Meredith
Verani, Jennifer R.
Thornburg, Natalie J.
Surie, Diya
Burnette, Joy
Capo, Gustavo
Epstein, Lauren
Gallini, Julia
Harrison, Telisha
Hartley, Amy
Hernandez, Liliana
Morales, Elena
Patel, Nina
Rooney, Kim
Tanner, Tehquin
Tate, Ernest
Tunson, Ashley
Whitmire, Alexis
Winston, Juton
Elliot, Katherine
Graham, Ilda
Lama, Diki
Pena, Ismael
Perea, Adrienne
Perez, Guerry Anabelle
Simelane, Johane
Smith, Sarah
Tallin, Gabriela
Tisi, Amelia
Lopez, Alonso Arellano
Gonzalez, Miguel Covarrubias
Lengi, Bashir
Tamez, Mariana Vanoye
Aryanfar, Babak
Lee-Chang, Ian
Matolek, Anthony
Poteshkina, Aleksandra
Naeem, Saadia
Goldin, Evan
Agrawal, Madhuri
Lopez, Jessica
Peters, Theresa
Kudryavtseva, Geliya
Cates, Jordan
Kambhampati, Anita
author_facet Bajema, Kristina L.
Dahl, Rebecca M.
Evener, Steve L.
Prill, Mila M.
Rodriguez-Barradas, Maria C.
Marconi, Vincent C.
Beenhouwer, David O.
Holodniy, Mark
Lucero-Obusan, Cynthia
Brown, Sheldon T.
Tremarelli, Maraia
Epperson, Monica
Mills, Lisa
Park, So Hee
Rivera-Dominguez, Gilberto
Morones, Rosalba Gomez
Ahmadi-Izadi, Ghazal
Deovic, Rijalda
Mendoza, Chad
Jeong, Chan
Schrag, Stephanie J.
Meites, Elissa
Hall, Aron J.
Kobayashi, Miwako
McMorrow, Meredith
Verani, Jennifer R.
Thornburg, Natalie J.
Surie, Diya
Burnette, Joy
Capo, Gustavo
Epstein, Lauren
Gallini, Julia
Harrison, Telisha
Hartley, Amy
Hernandez, Liliana
Morales, Elena
Patel, Nina
Rooney, Kim
Tanner, Tehquin
Tate, Ernest
Tunson, Ashley
Whitmire, Alexis
Winston, Juton
Elliot, Katherine
Graham, Ilda
Lama, Diki
Pena, Ismael
Perea, Adrienne
Perez, Guerry Anabelle
Simelane, Johane
Smith, Sarah
Tallin, Gabriela
Tisi, Amelia
Lopez, Alonso Arellano
Gonzalez, Miguel Covarrubias
Lengi, Bashir
Tamez, Mariana Vanoye
Aryanfar, Babak
Lee-Chang, Ian
Matolek, Anthony
Poteshkina, Aleksandra
Naeem, Saadia
Goldin, Evan
Agrawal, Madhuri
Lopez, Jessica
Peters, Theresa
Kudryavtseva, Geliya
Cates, Jordan
Kambhampati, Anita
author_sort Bajema, Kristina L.
collection PubMed
description
format Online
Article
Text
id pubmed-8659185
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-86591852021-12-23 Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021 Bajema, Kristina L. Dahl, Rebecca M. Evener, Steve L. Prill, Mila M. Rodriguez-Barradas, Maria C. Marconi, Vincent C. Beenhouwer, David O. Holodniy, Mark Lucero-Obusan, Cynthia Brown, Sheldon T. Tremarelli, Maraia Epperson, Monica Mills, Lisa Park, So Hee Rivera-Dominguez, Gilberto Morones, Rosalba Gomez Ahmadi-Izadi, Ghazal Deovic, Rijalda Mendoza, Chad Jeong, Chan Schrag, Stephanie J. Meites, Elissa Hall, Aron J. Kobayashi, Miwako McMorrow, Meredith Verani, Jennifer R. Thornburg, Natalie J. Surie, Diya Burnette, Joy Capo, Gustavo Epstein, Lauren Gallini, Julia Harrison, Telisha Hartley, Amy Hernandez, Liliana Morales, Elena Patel, Nina Rooney, Kim Tanner, Tehquin Tate, Ernest Tunson, Ashley Whitmire, Alexis Winston, Juton Elliot, Katherine Graham, Ilda Lama, Diki Pena, Ismael Perea, Adrienne Perez, Guerry Anabelle Simelane, Johane Smith, Sarah Tallin, Gabriela Tisi, Amelia Lopez, Alonso Arellano Gonzalez, Miguel Covarrubias Lengi, Bashir Tamez, Mariana Vanoye Aryanfar, Babak Lee-Chang, Ian Matolek, Anthony Poteshkina, Aleksandra Naeem, Saadia Goldin, Evan Agrawal, Madhuri Lopez, Jessica Peters, Theresa Kudryavtseva, Geliya Cates, Jordan Kambhampati, Anita MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2021-12-10 /pmc/articles/PMC8659185/ /pubmed/34882654 http://dx.doi.org/10.15585/mmwr.mm7049a2 Text en https://creativecommons.org/licenses/by/3.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.
spellingShingle Full Report
Bajema, Kristina L.
Dahl, Rebecca M.
Evener, Steve L.
Prill, Mila M.
Rodriguez-Barradas, Maria C.
Marconi, Vincent C.
Beenhouwer, David O.
Holodniy, Mark
Lucero-Obusan, Cynthia
Brown, Sheldon T.
Tremarelli, Maraia
Epperson, Monica
Mills, Lisa
Park, So Hee
Rivera-Dominguez, Gilberto
Morones, Rosalba Gomez
Ahmadi-Izadi, Ghazal
Deovic, Rijalda
Mendoza, Chad
Jeong, Chan
Schrag, Stephanie J.
Meites, Elissa
Hall, Aron J.
Kobayashi, Miwako
McMorrow, Meredith
Verani, Jennifer R.
Thornburg, Natalie J.
Surie, Diya
Burnette, Joy
Capo, Gustavo
Epstein, Lauren
Gallini, Julia
Harrison, Telisha
Hartley, Amy
Hernandez, Liliana
Morales, Elena
Patel, Nina
Rooney, Kim
Tanner, Tehquin
Tate, Ernest
Tunson, Ashley
Whitmire, Alexis
Winston, Juton
Elliot, Katherine
Graham, Ilda
Lama, Diki
Pena, Ismael
Perea, Adrienne
Perez, Guerry Anabelle
Simelane, Johane
Smith, Sarah
Tallin, Gabriela
Tisi, Amelia
Lopez, Alonso Arellano
Gonzalez, Miguel Covarrubias
Lengi, Bashir
Tamez, Mariana Vanoye
Aryanfar, Babak
Lee-Chang, Ian
Matolek, Anthony
Poteshkina, Aleksandra
Naeem, Saadia
Goldin, Evan
Agrawal, Madhuri
Lopez, Jessica
Peters, Theresa
Kudryavtseva, Geliya
Cates, Jordan
Kambhampati, Anita
Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021
title Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021
title_full Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021
title_fullStr Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021
title_full_unstemmed Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021
title_short Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021
title_sort comparative effectiveness and antibody responses to moderna and pfizer-biontech covid-19 vaccines among hospitalized veterans — five veterans affairs medical centers, united states, february 1–september 30, 2021
topic Full Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659185/
https://www.ncbi.nlm.nih.gov/pubmed/34882654
http://dx.doi.org/10.15585/mmwr.mm7049a2
work_keys_str_mv AT bajemakristinal comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT dahlrebeccam comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT evenerstevel comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT prillmilam comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT rodriguezbarradasmariac comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT marconivincentc comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT beenhouwerdavido comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT holodniymark comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT luceroobusancynthia comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT brownsheldont comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT tremarellimaraia comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT eppersonmonica comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT millslisa comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT parksohee comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT riveradominguezgilberto comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT moronesrosalbagomez comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT ahmadiizadighazal comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT deovicrijalda comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT mendozachad comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT jeongchan comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT schragstephaniej comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT meiteselissa comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT hallaronj comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT kobayashimiwako comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT mcmorrowmeredith comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT veranijenniferr comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT thornburgnataliej comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT suriediya comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT burnettejoy comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT capogustavo comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT epsteinlauren comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT gallinijulia comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT harrisontelisha comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT hartleyamy comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT hernandezliliana comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT moraleselena comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT patelnina comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT rooneykim comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT tannertehquin comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT tateernest comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT tunsonashley comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT whitmirealexis comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT winstonjuton comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT elliotkatherine comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT grahamilda comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT lamadiki comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT penaismael comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT pereaadrienne comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT perezguerryanabelle comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT simelanejohane comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT smithsarah comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT tallingabriela comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT tisiamelia comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT lopezalonsoarellano comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT gonzalezmiguelcovarrubias comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT lengibashir comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT tamezmarianavanoye comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT aryanfarbabak comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT leechangian comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT matolekanthony comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT poteshkinaaleksandra comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT naeemsaadia comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT goldinevan comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT agrawalmadhuri comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT lopezjessica comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT peterstheresa comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT kudryavtsevageliya comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT catesjordan comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021
AT kambhampatianita comparativeeffectivenessandantibodyresponsestomodernaandpfizerbiontechcovid19vaccinesamonghospitalizedveteransfiveveteransaffairsmedicalcentersunitedstatesfebruary1september302021